CAC
EDIT icon

Cowen and Company’s Editas Medicine EDIT Stock Holding History

Cowen and Company’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-34,800
Closed -$2K – 674
2021
Q3 		$2K Buy
+34,800
New +$1.91M ﹤0.01% 561
2021
Q2 		– Sell
-24,200
Closed -$7K – 619
2021
Q1 		$7K Buy
+24,200
New +$1.38M ﹤0.01% 500

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Cowen and Company's EDIT Position: Q4 2021 in Review

Cowen and Company sold out of Editas Medicine (EDIT) in Q4 2021, closing a stake of 2,362 shares — an estimated $97K sold.

Cowen and Company first reported a position in EDIT in Q3 2021 and held it in 1 quarter. The position peaked at $97K in Q3 2021. 306 funds tracked by Wall St. Rank hold EDIT as of Q4 2021.

  • Cowen and Company reported no remaining Editas Medicine position as of Q4 2021 after selling out during the quarter.
  • Cowen and Company sold 2,362 Editas Medicine shares in Q4 2021, an estimated $97K.
  • Cowen and Company first reported a position in Editas Medicine in Q3 2021 and held it in 1 quarter.
  • Cowen and Company's Editas Medicine position peaked at $97K in Q3 2021.
  • 306 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2021.

Based on Cowen and Company's 13F filing for Q4 2021, filed 14 Feb 2022.